Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Netherlands-based argenx has published positive topline results from its ADAPT SERON trial of its market-leading drug for generalised myasthenia gravis (gMG) Vyvgart (efgartigimod). Significantly, the ...
Grab invests in May Mobility as robotaxi startup expands to Southeast Asia May Mobility said on Thursday it has secured a significant equity investment from Singapore-based ridehailing firm Grab , as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback